Clinical Trial Update: Tolerability to HS-20004 With Titration Administration in Type 2 Diabetic Patients [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating tolerability of HS-20004 with titration administration in adults with Type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• HS-20004

Snippet

Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd. | Conditions: Diabetes Mellitus, Type 2 | Phase 1 | Status: UNKNOWN